drugset / Trial / NCT00791323
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
RandomizedParallel-groupDouble-blindBasic science
Summary
A pilot study to evaluate the extent of PGE2 inhibition (mean aqueous values) by Ketorolac 0.04% following peripheral iridotomy
Timeline
- Start
- 2008-11
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 0.4 % | Topical |
Indications
No indication recorded.